Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Lichtman, B. Martin (2002)
Marijuana Withdrawal Syndrome in the Animal ModelThe Journal of Clinical Pharmacology, 42
G. Aston-Jones, J. Rajkowski, J. Cohen (1999)
Role of locus coeruleus in attention and behavioral flexibilityBiological Psychiatry, 46
S. Foote, F. Bloom, G. Aston-Jones (1983)
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity.Physiological reviews, 63 3
A. Troisi, A. Pasini, M. Saracco, G. Spalletta (1998)
Psychiatric symptoms in male cannabis users not using other illicit drugs.Addiction, 93 4
John Williams, M. Christie, O. Manzoni (2001)
Cellular and synaptic adaptations mediating opioid dependence.Physiological reviews, 81 1
G. Aston-Jones, S. Foote, F. Bloom (1984)
Anatomy and physiology of locus coeruleus neurons: functional implicationsFrontiers of clinical neuroscience, 2
M. Arendt, P. Munk-Jørgensen (2004)
Heavy cannabis users seeking treatmentSocial Psychiatry and Psychiatric Epidemiology, 39
J. Manzanares, L. Urigüen, G. Rubio, T. Palomo (2009)
Role of endocannabinoid system in mental diseasesNeurotoxicity Research, 6
D. Morilak, A. Frazer (2004)
Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders.The international journal of neuropsychopharmacology, 7 2
B. Leonard (1997)
Noradrenaline in basic models of depressionEuropean Neuropsychopharmacology, 7
F. Berrendero, R. Maldonado (2002)
Involvement of the opioid system in the anxiolytic-like effects induced by Δ9-tetrahydrocannabinolPsychopharmacology, 163
C. Dackis, Charles O'Brien (2001)
Cocaine dependence: a disease of the brain's reward centers.Journal of substance abuse treatment, 21 3
A. Zuardi, I. Shirakawa, E. Finkelfarb, I. Karniol (1982)
Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.Psychopharmacology, 76 3
M. Aceto, S. Scates, Billy Martin (2001)
Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2.European journal of pharmacology, 416 1-2
K. Grasing, Dan Bills, Suchandra Ghosh, Stephan Schlussman, Amrish Patel, J. Woodward (1997)
Opiate Modulation of Striatal Dopamine and Hippocampal Norepinephrine Release Following Morphine WithdrawalNeurochemical Research, 22
R. Valentino, S. Foote, M. Page (1993)
The Locus Coeruleus as a Site for Integrating Corticotropin‐Releasing Factor and Noradrenergic Mediation of Stress Responses aAnnals of the New York Academy of Sciences, 697
(1984)
Norepinephrine (Frontiers of Clinical Neuroscience). Baltimore: Williams and Wilkins
C. Belzung, G. Griebel (2001)
Measuring normal and pathological anxiety-like behaviour in mice: a reviewBehavioural Brain Research, 125
Gary Aston-Jones, C. Chiang, T. Alexinsky (1991)
Discharge of noradrenergic locus coeruleus neurons in behaving rats and monkeys suggests a role in vigilance.Progress in brain research, 88
S. Kathuria, S. Gaetani, D. Fegley, F. Valiño, A. Duranti, A. Tontini, M. Mor, G. Tarzia, G. Rana, A. Calignano, A. Giustino, M. Tattoli, M. Palmery, V. Cuomo, D. Piomelli (2003)
Modulation of anxiety through blockade of anandamide hydrolysisNature Medicine, 9
Leonard (1997)
Noradrenaline in basic models of depressionJ Psychopharmacol, 11
Mariluz Hernández, F. Berrendero, I. Suárez, L. Garcı́a-Gil, M. Cebeira, K. Mackie, J. Ramos, J. Fernández-Ruiz (2000)
Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzymeBrain Research, 857
(2004)
Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience; Cannabinoid receptor activation modulates frontal cortical norepinephrine efflux in rat
F. Weiss, L. Porrino (2002)
Behavioral Neurobiology of Alcohol Addiction: Recent Advances and ChallengesThe Journal of Neuroscience, 22
M. Navarro, Elena Hernández, R. Muñoz, I. Arco, M. Villanúa, M. Carrera, F. Fonseca (1997)
Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety‐like responses in the ratNeuroReport, 8
M. Jouvet (1969)
Biogenic amines and the states of sleep.Science, 163 3862
A. Bonnin, R. Miguel, M. Hernández, J. Ramos, J. Fernández-Ruiz (1995)
The prenatal exposure to delta 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development.Life sciences, 56 23-24
G. Koob, R. Maldonado, L. Stinus (1992)
Neural substrates of opiate withdrawalTrends in Neurosciences, 15
S. González, J. Fernández-Ruiz, V. Marzo, Mariluz Hernández, C. Arévalo, Cristina Nicanor, M. Cascio, E. Ambrosio, J. Ramos (2004)
Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.Drug and alcohol dependence, 74 2
J. Gregg, E. Small, R. Moore, D. Raft, T. Toomey (1976)
Emotional response to intravenous delta9tetrahydrocannabinol during oral surgery.Journal of oral surgery, 34 4
Oropeza (2004)
Cannabinoid receptor activation modulates frontal cortical norepinephrine efflux in rat brain
E. Bockstaele, J. Peoples, R. Valentino (1999)
Anatomic basis for differential regulation of the rostrolateral peri–locus coeruleus region by limbic afferentsBiological Psychiatry, 46
J. Dimsdale, D. O'Connor, M. Ziegler, P. Mills (1989)
Does chromogranin a respond to short-term mild physiologic challenge?Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2 3
M. Page, Paul Szeliga, F. Gasparini, J. Cryan (2005)
Blockade of the mGlu5 receptor decreases basal and stress-induced cortical norepinephrine in rodentsPsychopharmacology, 179
G. Paxinos, Charles Watson (1983)
The Rat Brain in Stereotaxic Coordinates
M. Page, I. Lucki (2002)
Effects of Acute and Chronic Reboxetine Treatment on Stress-induced Monoamine Efflux in the Rat Frontal CortexNeuropsychopharmacology, 27
A. Bonnin, R. Miguel, J. Fernández-Ruiz, M. Cebeira, J. Ramos (1994)
Possible role of the cytochrome P450-linked monooxygenase system in preventing delta 9-tetrahydrocannabinol-induced stimulation of tuberoinfundibular dopaminergic activity in female rats.Biochemical pharmacology, 48 7
M. Persson, D. Wasserman, T. Geijer, E. Jönsson, L. Terenius (1997)
Tyrosine hydroxylase allelic distribution in suicide attemptersPsychiatry Research, 72
S. Sands, R. Strong, J. Corbitt, D. Morilak (2000)
Effects of acute restraint stress on tyrosine hydroxylase mRNA expression in locus coeruleus of Wistar and Wistar-Kyoto rats.Brain research. Molecular brain research, 75 1
V. Oropeza, M. Page, M. Page, E. Bockstaele (2005)
Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortexBrain Research, 1046
Jian Liu, JohnP Merlie, Richard Todd, Karen O'Malley (1997)
Identification of cell type-specific promoter elements associated with the rat tyrosine hydroxylase gene using transgenic founder analysis.Brain research. Molecular brain research, 50 1-2
Toshiaki Shishido, Yoshinori Watanabe, Isao Matsuoka, Hironori Nakanishi, Shin-Ichi Niwa (1997)
Acute methamphetamine administration increases tyrosine hydroxylase mRNA levels in the rat locus coeruleus.Brain research. Molecular brain research, 52 1
Xavier Guitart, Michael Hayward, Laura Nisenbaum, Dana Beitner‐Johnson, J. Haycock, Eric Nestler (1990)
Identification of MARPP-58, a morphine- and cyclic AMP-regulated phosphoprotein of 58 kDa, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat locus coeruleus, 10
M. Arendt (2002)
Heavy cannabis users seeking treatment: prevalence of psychiatric disordersEuropean Psychiatry, 17
L. Degenhardt, Wayne Hall, M. Lynskey (2001)
The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-BeingSocial Psychiatry and Psychiatric Epidemiology, 36
H. Kalant (2004)
Adverse effects of cannabis on health: an update of the literature since 1996Progress in Neuro-Psychopharmacology and Biological Psychiatry, 28
J. Arnold, A. Topple, P. Mallet, G. Hunt, I. McGregor (2001)
The distribution of cannabinoid-induced Fos expression in rat brain: differences between the Lewis and Wistar strainBrain Research, 921
J. Morgan, T. Curran (1986)
Role of ion flux in the control of c-fos expressionNature, 322
G. Dawson, M. Tricklebank (1995)
Use of the elevated plus maze in the search for novel anxiolytic agents.Trends in pharmacological sciences, 16 2
R. Meyer, R. Pillard, L. Shapiro, S. Mirin (1971)
Administration of marijuana to heavy and casual marijuana users.The American journal of psychiatry, 128 2
D. Swanson, E. Zellmer, E. Lewis (1998)
AP1 Proteins Mediate the cAMP Response of the Dopamine β-Hydroxylase Gene*The Journal of Biological Chemistry, 273
F. Fonseca, P. Rubio, F. Menzaghi, E. Merlo-Pich, J. Rivier, G. Koob, M. Navarro (1996)
Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.The Journal of pharmacology and experimental therapeutics, 276 1
V. Oropeza, K. Mackie, E. Bockstaele (2007)
Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortexBrain Research, 1127
G. Aston-Jones, F. Bloom (1981)
Nonrepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli, 1
F. Berrendero, Rafael Maldonado (2002)
Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.Psychopharmacology, 163 1
R. Maldonado (2002)
Study of cannabinoid dependence in animals.Pharmacology & therapeutics, 95 2
A. Bonnin, R. Miguel, J. Castro, J. Ramos, J. Fernández-Ruiz (2007)
Effects of perinatal exposure to Δ9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brainJournal of Molecular Neuroscience, 7
V. Boundy, S. Gold, C. Messer, Jingshan Chen, J. Son, T. Joh, Eric Nestler (1998)
Regulation of Tyrosine Hydroxylase Promoter Activity by Chronic Morphine in TH9.0-LacZ Transgenic MiceThe Journal of Neuroscience, 18
Pharmacology Biochemistry and Behavior – Unpaywall
Published: Jan 1, 2007
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.